Haleon (LON:HLN) Sets New 1-Year Low - Here's Why

Key Points

• Haleon plc has hit a new 52-week low with shares trading as low as GBX 346.10 ($4.59) during mid-day trading.
• The company reported a quarterly EPS of GBX 8.90 ($0.12) and has a return on equity of 6.54% with a net margin of 9.66%.
• Insider transactions include the sale of 64,329 shares by Dawn Allen and the purchase of 21,300 shares by Marie-Anne Aymerich within the past three months.

Haleon plc (LON:HLN - Get Free Report) shares hit a new 52-week low during trading on Thursday . The stock traded as low as GBX 346.10 ($4.60) and last traded at GBX 352.60 ($4.68), with a volume of 226846969 shares. The stock had previously closed at GBX 364.90 ($4.85).

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the stock. Royal Bank Of Canada reissued a "sector perform" rating and set a GBX 370 ($4.91) price target on shares of Haleon in a research report on Thursday. JPMorgan Chase & Co. reaffirmed an "underweight" rating on shares of Haleon in a report on Friday.

Haleon Trading Down 2.7%

The stock has a fifty day moving average of GBX 381.70 and a 200 day moving average of GBX 385.29. The company has a debt-to-equity ratio of 53.36, a quick ratio of 0.93 and a current ratio of 0.84. The company has a market capitalization of £32.11 billion, a PE ratio of 29.92, a PEG ratio of 1.49 and a beta of 0.19.

Haleon (LON:HLN - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The company reported GBX 8.90 ($0.12) EPS for the quarter. Haleon had a net margin of 9.66% and a return on equity of 6.54%. As a group, sell-side analysts predict that Haleon plc will post 19.5033282 earnings per share for the current fiscal year.

Insider Activity

In related news, insider Blathnaid Bergin bought 6,145 shares of the company's stock in a transaction on Friday, May 16th. The shares were acquired at an average cost of GBX 404 ($5.36) per share, for a total transaction of £24,825.80 ($32,964.81). Also, insider Marie-Anne Aymerich bought 21,300 shares of the company's stock in a transaction on Friday, May 9th. The stock was bought at an average price of GBX 405 ($5.38) per share, for a total transaction of £86,265 ($114,546.54). Corporate insiders own 10.74% of the company's stock.

Haleon Company Profile

Haleon LSE / NYSE: HLN is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other.